SCHEMBL6023929

SCHEMBL6023929

CCCCCCOc1cc(C=CC(=O)Nc2ccccc2O)cc(OCCCCCC)c1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.57
MMP1 P03956 5/20 0.54
MMP2 P08253 5/20 0.54
MMP9 P14780 5/20 0.54
TRPA1 O75762 1/20 0.51
CYSLTR2 Q9NS75 1/20 0.49
CYSLTR1 Q9Y271 1/20 0.49
EGFR P00533 1/20 0.49
ALDH1A1 P00352 4/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
PKM P14618 1/20 0.48
HTT P42858 1/20 0.48
NLRP1 Q9C000 1/20 0.48
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
KDM4E B2RXH2 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6023926 1.00 KDM1A (0.57) KDM1AMMP1MMP2MMP9TRPA1
SCHEMBL6023707 0.87 BCHE (0.60) KDM1ABCHEACHE
SCHEMBL6023711 0.87 BCHE (0.60) KDM1ABCHEACHE
SCHEMBL6022690 0.82 MMP1 (0.59) MMP1MMP2MMP9BCHEACHE
SCHEMBL6022688 0.82 MMP1 (0.59) MMP1MMP2MMP9BCHEACHE
SCHEMBL9219010 0.81 KDM1A (0.58) KDM1AMAPTKMT2AMEN1BCHE
SCHEMBL9218998 0.81 KDM1A (0.58) KDM1AMAPTKMT2AMEN1BCHE
SCHEMBL8755877 0.80 MMP1 (0.67) MMP1MMP2MMP9TRPA1CYSLTR2
SCHEMBL8755882 0.80 MMP1 (0.67) MMP1MMP2MMP9TRPA1CYSLTR2
SCHEMBL6022727 0.80 KDM1A (0.60) KDM1AMMP1MMP2MMP9TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US claimed
US-7078407-B2 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2006-07-18 US disclosed
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162789-A1 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them HTT, PARK7, NQO1 KDM1A 2590/4885MMP1 2333/4885MMP2 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.